Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2025-12-24 @ 7:09 PM
NCT ID:
NCT07112157
Eligibility Criteria:
Inclusion Criteria:
* The patients to be treated with strabismus correction under general anesthesia are 3-60 years old, regardless of gender.
The American Society of anesthesiologists (ASA) classification is Ⅰ - Ⅱ. Patients or their guardians (for child patients) voluntarily participated in the trial and signed the informed consent form with informed consent.
Exclusion Criteria:
* Those who are allergic to oxalidine, sufentanil or any of the ingredients in their preparations.
Patients with severe heart, liver, kidney and other important organ dysfunction.
Have a history of epilepsy or central nervous system disease. Other opioid analgesics were used within 48 hours before operation. Pregnant or lactating women. Patients with mental disorders who are unable to cooperate to complete the test related assessment.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
60 Years
Study:
NCT07112157
Study Brief:
Protocol Section:
NCT07112157